Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT06842849
Recruiting Not applicable

Impact of a Physical Exercise Program in a Rural Area

NCT06842849 · tracked via the Priya Life Science Spain tracker
Sponsor
University of Valencia
Phase
Not applicable
Started
2025-10-22
Last updated
2026-09-11

Condition(s) studied

Old Age; Debility

Investigational drug(s) / intervention(s)

Exercise program

Exercise program: Multimodal and multicompetent exercise program 2 days a week for 60 minutes and 1 day of walking exercise for 60 minutes.

Study summary

With this work we want to assess whether there are differences in the amount of physical activity per week, measured by accelerometry in 3 groups of subjects, where one group (G1) has been carrying out a PA program called "Enguera Sé Saludable" for a year. another group (G2) newly introduced to the same exercise program, and a control group (G3) that does not carry out an exercise program but declared itself active.

Eligibility

Sex
ALL
Min age
59 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults over 59 years of age. * Patients who comply with accelerometer times for 7 days. * Patients who correctly complete the accelerometer registration sheet. * Patients who complete the informed consent Exclusion Criteria: * Patients who do not wear the accelerometer 600 minutes a day for at least 3 days on weekdays and 480 minutes for at least 1 day on the weekend. * Patients who suffer from illness during data collection. * Patients who do not wear the accelerometer for 7 days. Be in IPAQ category 1 (low level of AF).

Primary outcome measure(s)

  • MVPA — 1 year
    Mooderate to vigorous amount of activity. Assess the amount of moderate to vigorous exercise during accelerometry for one week.

Trial sites (1)

FacilityCityRegionStatus
Universitat de València Valencia Spain Recruiting

More University of Valencia trials in Spain

Resistance Exercise in Patients With Ocular Melanoma Recruiting
Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis Recruiting
Effectiveness of Virtual Reality in Parkinson's Disease: Effects on Balance, Fall Risk, and Exercise Capacity. Starting soon
Pain Neuroscience Education for Chronic Pain Enrolling by invitation
Implementation of a Suicide Prevention Gatekeeper Program in the University Setting Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06842849 on ClinicalTrials.gov ↗ ← All trials in Spain